Deciphera Pharmaceuticals, Inc. Gross Profit
Deciphera Pharmaceuticals, Inc. reported Gross Profit of $19.36 million for the 3-month period ending 2020-12-31, per its 10-K filed 2021-02-09.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2021-02-09
- Deciphera Pharmaceuticals, Inc. gross profit for the quarter ending 2020-12-31 was $19.36M.
- Deciphera Pharmaceuticals, Inc. gross profit for the quarter ending 2020-09-30 was $15.36M.
- Deciphera Pharmaceuticals, Inc. gross profit for the quarter ending 2020-06-30 was $7.08M, a 71.67% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. gross profit for the quarter ending 2020-03-31 was $62.00K.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2020-12-31 | $19.36M 10-K · filed 2021-02-09 | $34.72M derived: sum of 2 quarters · filed 2021-02-09 | $41.80M derived: sum of 3 quarters · filed 2021-02-09 | $41.86M derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-09-30 | $15.36M 10-K · filed 2021-02-09 | $22.44M derived: sum of 2 quarters · filed 2021-02-09 | $22.50M derived: sum of 3 quarters · filed 2021-02-09 | $22.50M derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-06-30 | $7.08M 10-K · filed 2021-02-09 | $7.14M derived: sum of 2 quarters · filed 2021-02-09 | $7.14M derived: sum of 3 quarters · filed 2021-02-09 | $7.14M derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-03-31 | $62.00K 10-K · filed 2021-02-09 | $62.00K derived: sum of 2 quarters · filed 2021-02-09 | $62.00K derived: sum of 3 quarters · filed 2021-02-09 | $25.06M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-09 | $0.00 derived: sum of 2 quarters · filed 2021-02-09 | $25.00M derived: sum of 3 quarters · filed 2021-02-09 | $25.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-09-30 | $0.00 10-K · filed 2021-02-09 | $25.00M derived: sum of 2 quarters · filed 2021-02-09 | $25.00M derived: sum of 3 quarters · filed 2021-02-09 | |
| 2019-06-30 | $25.00M 10-K · filed 2021-02-09 | $25.00M derived: sum of 2 quarters · filed 2021-02-09 | ||
| 2019-03-31 | $0.00 10-K · filed 2021-02-09 |